News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Muhammad Umair Mushtaq: Comparative Study of Daratumumab Regimens in Myeloma
Muhammad Umair Mushtaq/LinkedIn
Sep 1, 2025, 08:50

Muhammad Umair Mushtaq: Comparative Study of Daratumumab Regimens in Myeloma

Muhammad Umair Mushtaq, Associate Professor of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, shared a post on LinkedIn about a recently published article on multiple myeloma therapies, co-authored by him and colleagues:

“Efficacy and Safety of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Multicenter Real-World Experience. Clinical Lymphoma, Myeloma and Leukemia. 2025″

Title: Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Multicenter Real-World Experience

Authors: Anas Zayad, Gray Magee, Razan Mansour, Mark Chang, Nausheen Ahmed, Muhammad Umair Mushtaq, Barry Paul, Kimberly M. Green, James A. Davis, Barry Skikne, Zahra Mahmoud Jafari, Jeries Kort, Shebli Atrash, Al-Ola Abdallah

Read the Full Article in Science Direct.

Muhammad Umair Mushtaq

More posts featuring Muhammad Umair Mushtaq on OncoDaily.

Al-Ola Abdallah Anas Zayad Barry Paul Barry Skikne cancer Carfilzomib Daratumumab dexamethasone Gray Magee James A. Davis Jeries Kort Kimberly M. Green Mark Chang Muhammad Umair Mushtaq Nausheen Ahmed OncoDaily Oncology Pomalidomide Razan Mansour relapsed multiple myeloma Science Direct Shebli Atrash Zahra Mahmoud Jafari
Special Coverage
Science
Sep 1, 2025, 08:50
Muhammad Umair Mushtaq: Comparative Study of Daratumumab Regimens in Myeloma
Voices
Sep 1, 2025, 08:47
Hiba Al-Tarrah Honored to Meet Saudi Health and Humanitarian Leaders
Blog Posts
Sep 1, 2025, 08:45
Kleva Qeraj Reflects on Her Breast Cancer Observership at IEO - European School of Oncology
Voices
Sep 1, 2025, 08:39
Asfand Yar Cheema: Leading the Way in Hematology Research at SOHO 2025
Voices
Sep 1, 2025, 08:30
Paolo Ascierto on Gordon Ramsay's Skin Cancer Awareness Message
Career Updates
Sep 1, 2025, 08:13
Jemma Arakelyan: Farewell to My Academic Home, Joining a Leader in Anticancer Drug Discovery
Career Updates
Sep 1, 2025, 07:54
Emma Tadevosyan: Honored to Complete St. Jude Global Academy Qualitative Research Training
Voices
Sep 1, 2025, 07:34
Stephen V Liu: A Helpful Guide to Avoid Grand Rounds Pitfalls
Science
Sep 1, 2025, 07:27
Lekha Mikkilineni: Studying Stem Cell Mobilization in the CD38-mAb Era
Voices
Sep 1, 2025, 07:26
Herbert Loong: Excellent Summary by Aakash Desai for WCLC25
Voices
Sep 1, 2025, 07:11
Herbert Loong: Join Us on Sunday for a Special Session on Global Lung Cancer Policy at WCLC 2025
Blog Posts
Sep 1, 2025, 07:07
Nicole Grogan Fleege: ASCO QLTY25 - The Perfect Conference for Networking and Learning